
|Articles|October 1, 2001
- Pharmaceutical Executive-10-01-2001
- Volume 0
- Issue 0
National Crisis Supercedes Coverage Debate
Government and industry have shown they can work together to deal with a national disaster.
Advertisement
Articles in this issue
almost 25 years ago
PBMs: Merck-Medco in the Hot Seatalmost 25 years ago
National Crisis Supercedes Coverage Debatealmost 25 years ago
A Five-Year Forecast: Clear Seas Ahead?almost 25 years ago
Weak Bones, Strong Marketalmost 25 years ago
Approvals: Novartis’ Silver Liningalmost 25 years ago
Pfizer and others Pitch Inalmost 25 years ago
Oncology: EMEA Approval Lagsalmost 25 years ago
Illegal Sales in Indiaalmost 25 years ago
Health Plan Premiums: Pharma Takes the Blamealmost 25 years ago
Little Elan Becomes a Big DealAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma
3
Novartis to Layoff 322 NJ Employees: Report
4
Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena
5




